DK162385A - Implanterbare praeparater af regulatoriske peptider med styret frigoerelse og fremgangsmaade til fremstilling heraf - Google Patents

Implanterbare praeparater af regulatoriske peptider med styret frigoerelse og fremgangsmaade til fremstilling heraf Download PDF

Info

Publication number
DK162385A
DK162385A DK162385A DK162385A DK162385A DK 162385 A DK162385 A DK 162385A DK 162385 A DK162385 A DK 162385A DK 162385 A DK162385 A DK 162385A DK 162385 A DK162385 A DK 162385A
Authority
DK
Denmark
Prior art keywords
procedures
producing
regulatory peptides
managed release
implantable preparations
Prior art date
Application number
DK162385A
Other languages
Danish (da)
English (en)
Other versions
DK162385D0 (da
Inventor
Juergen Kurt Sandow
Heinz-Ruediger Seidel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK162385D0 publication Critical patent/DK162385D0/da
Publication of DK162385A publication Critical patent/DK162385A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK162385A 1984-04-11 1985-04-10 Implanterbare praeparater af regulatoriske peptider med styret frigoerelse og fremgangsmaade til fremstilling heraf DK162385A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843413608 DE3413608A1 (de) 1984-04-11 1984-04-11 Implantierbare zubereitungen von regulatorischen peptiden mit gesteuerter freisetzung und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
DK162385D0 DK162385D0 (da) 1985-04-10
DK162385A true DK162385A (da) 1985-10-12

Family

ID=6233259

Family Applications (1)

Application Number Title Priority Date Filing Date
DK162385A DK162385A (da) 1984-04-11 1985-04-10 Implanterbare praeparater af regulatoriske peptider med styret frigoerelse og fremgangsmaade til fremstilling heraf

Country Status (12)

Country Link
EP (1) EP0158277A3 (enrdf_load_html_response)
JP (1) JPS60228411A (enrdf_load_html_response)
KR (1) KR850007559A (enrdf_load_html_response)
AU (1) AU4105985A (enrdf_load_html_response)
DE (1) DE3413608A1 (enrdf_load_html_response)
DK (1) DK162385A (enrdf_load_html_response)
ES (1) ES8607732A1 (enrdf_load_html_response)
GR (1) GR850905B (enrdf_load_html_response)
HU (1) HUT40760A (enrdf_load_html_response)
IL (1) IL74848A0 (enrdf_load_html_response)
PT (1) PT80252B (enrdf_load_html_response)
ZA (1) ZA852639B (enrdf_load_html_response)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79134A (en) * 1985-07-29 1991-06-10 American Cyanamid Co Continuous release peptide implants for parenteral administration
US5137874A (en) * 1985-07-29 1992-08-11 American Cyanamid Co. Partially coated C10 -C20 fatty acid salts of peptides having molecular weights up to about 5,000
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release
CA1257199A (en) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation containing bioactive macromolecular substance for multi-months release in vivo
AU601736B2 (en) * 1986-05-23 1990-09-20 Sanofi Sante Nutrition Animale Sa Coated veterinary implants
AU2902289A (en) * 1987-12-08 1989-07-05 Mark Chasin Method of forming bioerodible implants for improved controlled drug release
JP2590358B2 (ja) * 1988-03-01 1997-03-12 正雄 五十嵐 子宮内膜症治療用の子宮内又は膣内投与製剤
EP0550436A1 (en) * 1989-11-06 1993-07-14 Alkermes Controlled Therapeutics, Inc. Protein microspheres and methods of using them
CA2046830C (en) * 1990-07-19 1999-12-14 Patrick P. Deluca Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
AU692794B2 (en) 1993-08-30 1998-06-18 Baylor College Of Medicine Senescent cell-derived inhibitors of DNA synthesis
US5674888A (en) * 1995-06-07 1997-10-07 University Of California Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
US5599535A (en) * 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
US6020473A (en) * 1995-08-25 2000-02-01 Genentech, Inc. Nucleic acids encoding variants of vascular endothelial cell growth factor
US7005505B1 (en) 1995-08-25 2006-02-28 Genentech, Inc. Variants of vascular endothelial cell growth factor
US6100071A (en) 1996-05-07 2000-08-08 Genentech, Inc. Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
ES2285737T3 (es) 1996-08-30 2007-11-16 Peptech Limited Formula de liberacion prolongada de los agonistas y analogos peptidicos de gnrh.
US6475724B1 (en) 1997-01-28 2002-11-05 The Regents Of The University Of California Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US7138511B1 (en) 1997-01-28 2006-11-21 The Regents Of The University Of California Nucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6171788B1 (en) 1997-01-28 2001-01-09 The Regents Of The University Of California Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
EP2050762A3 (en) 1998-03-10 2009-07-08 Genentech, Inc. Human cornichon-like protein and nucleic acids encoding it
US7078382B1 (en) 1999-11-02 2006-07-18 Genentech, Inc. Modulation of eNOS activity and therapeutic uses thereof
US20040224000A1 (en) * 2003-05-05 2004-11-11 Romano Deghenghi Implants for non-radioactive brachytherapy of hormonal-insensitive cancers
CN106434833A (zh) 2004-05-23 2017-02-22 杰勒德·M·豪斯 Theramutein调节剂
US8431110B2 (en) 2005-05-23 2013-04-30 Hmi Medical Innovations, Llc. Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators
ES2391334T3 (es) 2005-06-21 2012-11-23 Xoma Technology Ltd. Anticuerpos y fragmentos de los mismos que se unen a la IL-1beta
ATE480267T1 (de) * 2006-01-05 2010-09-15 Med Inst Inc Zein-beschichtete medizinische vorrichtung
JP5645409B2 (ja) 2006-12-20 2014-12-24 ゾーマ （ユーエス） リミテッド ライアビリティ カンパニー ＩＬ−１β関連疾患の治療方法
EP2190448B1 (en) 2007-06-22 2016-04-20 Children's Medical Center Corporation Methods and uses thereof of a fragment of saposin a
WO2009067431A2 (en) 2007-11-20 2009-05-28 Cook Incorporated Controlled drug delivery using a zein layer modified with levulinic acid
CN101945891A (zh) 2007-12-20 2011-01-12 爱克索马技术有限公司 治疗痛风的方法
WO2010144797A2 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Influenza vaccines with enhanced immunogenicity and uses thereof
CN101669899B (zh) * 2009-09-29 2011-02-02 河北科技大学 玉米蛋白为主要骨架材料或基质的缓释埋植剂及其用途
CA2822026C (en) 2009-12-17 2018-06-12 Children's Medical Center Corporation Saposin-a derived peptides and uses thereof
EP3165531B1 (en) 2010-03-12 2020-11-25 Children's Medical Center Corporation Immunogenic composition, vaccine, and uses thereof
CN101843577A (zh) * 2010-04-08 2010-09-29 安徽中医学院 以玉米醇溶蛋白为骨架材料的包衣植入剂及制备方法
CN104203275A (zh) 2010-06-09 2014-12-10 疫苗技术股份有限公司 用于增强抗逆转录病毒治疗的hiv感染者的治疗性免疫
WO2012092539A2 (en) 2010-12-31 2012-07-05 Takeda Pharmaceutical Company Limited Antibodies to dll4 and uses thereof
KR102084509B1 (ko) 2011-05-11 2020-03-05 칠드런'즈 메디컬 센터 코포레이션 변형 비오틴-결합 단백질, 그 융합 단백질 및 응용
EP2744508B1 (en) 2011-08-19 2017-11-08 Children's Medical Center Corporation Vegf-binding protein for blockade of angiogenesis
EP3050900A1 (en) 2011-12-19 2016-08-03 Xoma (Us) Llc Methods for treating acne
AU2012358269B2 (en) 2011-12-22 2017-11-02 Children's Medical Center Corporation Saposin-A derived peptides and uses thereof
WO2013106485A2 (en) 2012-01-09 2013-07-18 The Scripps Research Institute Ultralong complementarity determining regions and uses thereof
EP3663314A1 (en) 2012-01-09 2020-06-10 The Scripps Research Institute Humanized antibodies with ultralong cdr3s
ES2959258T3 (es) 2013-02-07 2024-02-22 Childrens Medical Center Antígenos proteicos que proporcionan protección contra la colonización y/o la enfermedad neumocócicas
US10640574B2 (en) 2013-07-18 2020-05-05 Taurus Biosciences, Llc Humanized antibodies with ultralong complementary determining regions
US20160168231A1 (en) 2013-07-18 2016-06-16 Fabrus, Inc. Antibodies with ultralong complementarity determining regions
US10286078B2 (en) 2013-09-13 2019-05-14 The California Institute For Biomedical Research Modified therapeutic agents and compositions thereof
ES2741308T3 (es) 2013-10-15 2020-02-10 Scripps Research Inst Interruptores de células T con receptores de antígenos quiméricos y usos de los mismos
EP3057994B1 (en) 2013-10-15 2020-09-23 The Scripps Research Institute Peptidic chimeric antigen receptor t cell switches and uses thereof
EP4212180A1 (en) 2013-12-18 2023-07-19 The Scripps Research Institute Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof
EP2977758A1 (en) 2014-07-24 2016-01-27 Université De Nice Sophia Antipolis Methods and kits for monitoring membranous nephropathy
US10800828B2 (en) 2015-03-26 2020-10-13 The Scripps Research Institute Switchable non-scFv chimeric receptors, switches, and methods of use thereof to treat cancer
EP3283113A4 (en) 2015-04-15 2018-12-05 The California Institute for Biomedical Research Optimized pne-based chimeric receptor t cell switches and uses thereof
US20190000928A1 (en) 2015-06-17 2019-01-03 The California Institute For Biomedical Research Modified therapeutic agents and compositions thereof
KR20230172612A (ko) 2016-10-19 2023-12-22 더 스크립스 리서치 인스티튜트 인간화된 표적화 모이어티 및/또는 최적화된 키메라 항원 수용체-상호작용 도메인을 갖는 키메라 항원 수용체 효과기 세포 스위치 및 이의 용도
CN119409834A (zh) 2019-08-12 2025-02-11 北京恩瑞尼生物科技股份有限公司 用于通过cd39表达细胞的adcc靶向促进和增强t细胞介导的免疫反应的方法和组合物
CN115551594A (zh) 2019-10-24 2022-12-30 米诺陶治疗公司 经细胞因子修饰的嵌合抗体及其使用方法
WO2022232321A1 (en) 2021-04-28 2022-11-03 Minotaur Therapeutics, Inc. Humanized chimeric bovine antibodies and methods of use
KR20250006965A (ko) 2022-04-29 2025-01-13 퓨리노미아 바이오테크, 아이엔씨. 호산구에 의해 유발되는 질환 및 장애의 치료를 위한 방법 및 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE184774C (enrdf_load_html_response) *
US2895880A (en) * 1955-05-13 1959-07-21 Smith Kline French Lab Sustained release pharmaceutical product
GB935672A (en) * 1960-07-19 1963-09-04 Sterling Drug Inc Sustained release tablet
DE2242844A1 (de) * 1972-08-31 1974-04-11 Wolfgang Joachim Guettner Spruehmittel auf zein-basis
HUT35524A (en) * 1983-08-02 1985-07-29 Hoechst Ag Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance

Also Published As

Publication number Publication date
PT80252A (de) 1985-05-01
AU4105985A (en) 1985-10-17
IL74848A0 (en) 1985-07-31
DE3413608A1 (de) 1985-10-24
HUT40760A (en) 1987-02-27
EP0158277A2 (de) 1985-10-16
DK162385D0 (da) 1985-04-10
ES542045A0 (es) 1986-06-01
JPS60228411A (ja) 1985-11-13
GR850905B (enrdf_load_html_response) 1985-11-25
EP0158277A3 (de) 1987-04-29
ES8607732A1 (es) 1986-06-01
KR850007559A (ko) 1985-12-07
PT80252B (de) 1987-02-03
ZA852639B (en) 1985-11-27

Similar Documents

Publication Publication Date Title
DK162385A (da) Implanterbare praeparater af regulatoriske peptider med styret frigoerelse og fremgangsmaade til fremstilling heraf
DK495585D0 (da) Farmaceutisk praeparat med kontrolleret frigivelse og fremgangsmaade til fremstilling af samme
DK457984D0 (da) Fremgangsmaade til fremstilling af faste farmaceutiske praeparater med forsinket frigivelse
DK239489A (da) Fremgangsmaade til fremstilling af dialkyldisulfider og polysulfider
DK256485D0 (da) Veterinaert praeparat og fremgangsmaade til fremstilling deraf
DK546788A (da) Fremgangsmaade og anordning til oparbejdning af flyveaske
DK559387D0 (da) Fremgangsmaade og mellemprodukt til fremstilling af 3-pyrrolidinoler
DK314786D0 (da) Fremgangsmaade til fremstilling af proteiner og polypeptider
DK549087A (da) Gangliosidbeslaegtede forbindelser og fremgangsmaade til fremstilling af samme
DK38493D0 (da) Fremgangsmaade til fremstilling af alkoxymethylether- og alkoxymethylesterderivater af glyceroler
DK273585D0 (da) Fremgangsmaade til fremstilling af medicinske kosmetiske praeparater
DK393489A (da) Benzodiazepinforbindelser og fremgangsmaade til deres fremstilling
DK538488D0 (da) Pulverformigt yttrium-stabiliseret zirconiumoxid og fremgangsmaade til fremstilling af dette
DK261485A (da) Kosmetiske praeparater og fremgangsmaade til deres fremstilling
DK155886D0 (da) Vaccine og fremgangsmaade til fremstilling af denne
DK362987D0 (da) Hexahydroarylquinolizin og fremgangsmaade til fremstilling deraf
DK591788A (da) Fremgangsmaade til fremstilling af alkansulfonsyrer og alkansulfonylchlorider
DK440281A (da) Fremgangsmaade til fremstilling af n-carboxylalkyldipeptider og derivater deraf
NO851687L (no) Kryssbundne karboksyl-polyelektrolytter og fremgangsmaate for deres fremstilling
DK180588D0 (da) Anti-tumor-virksomme praeparater og fremgangsmaade til deres fremstilling
DK162475C (da) Terapeutisk praeparat indeholdende hydrogenerede ergotalkaloider og heparin og fremgangsmaade til fremstiling af praeparatet
DK670588A (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet
DK585686A (da) Form iii krystaller af n-alfa-(((s)-4-oxo-2-azetidinyl)carbonyl)-l-histidyl-l-prolinamid og fremgangsmaade til fremstilling af krystallerne
DK84183A (da) Benzyletherderivater af pentiter og fremgangsmaade til fremstilling deraf
DK296984D0 (da) 3-substituerede-3-aminonitriler og fremgangsmaade til deres fremstilling

Legal Events

Date Code Title Description
ATS Application withdrawn
ATS Application withdrawn
PBP Patent lapsed